Our observations show that ISL inhibits STAT3 phosphorylation in NPC cells, coupled with the finding that ectopic overexpression of STAT3 restores the migratory ability of ISL‐treated cells, strongly implicates the STAT3 pathway as a crucial target of ISL's anti‐metastatic effects. The gene discussed is STAT3; the disease is nasopharyngeal carcinoma.